Invention Grant
- Patent Title: Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelope
-
Application No.: US17010755Application Date: 2020-09-02
-
Publication No.: US11572403B2Publication Date: 2023-02-07
- Inventor: Francois Vigneault , Adrian Wrangham Briggs , Stephen J. Goldfless , Sonia Timberlake
- Applicant: AbVitro LLC
- Applicant Address: US WA Seattle
- Assignee: AbVitro LLC
- Current Assignee: AbVitro LLC
- Current Assignee Address: US WA Seattle
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/42 ; A61K39/395 ; A61P31/18 ; C07K16/46 ; C12N15/113 ; A61K39/00 ; A61K47/68
Abstract:
This invention relates to novel anti-HIV antibodies that can be used in the treatment and detection of human immunodeficiency virus (HIV). These antibodies exhibit a high degree of sensitivity and can provide a broad range of specificity.
Public/Granted literature
- US20210101963A1 HIV ANTIBODY COMPOSITIONS AND METHODS OF USE Public/Granted day:2021-04-08
Information query
